Aimmune Therapeutics, Inc. Contracts & Agreements
62 Contracts & Agreements
- Business Finance (18 contracts)
- Business Operations (7)
- Human Resources (20)
- Intellectual Property (1)
- Mergers & Acquisitions (1)
- Real Estate (7)
- Uncategorized (8)
- Agreement and Plan of Merger, dated as of August 29, 2020, by and among Aimmune Therapeutics, Inc., Socits des Produits Nestl S.A., and SPN MergerSub, Inc (Filed With SEC on August 31, 2020)
- Form of Global Stock Option Grant Notice and Award Agreement (Filed With SEC on July 31, 2020)
- Form of Global Restricted Stock Unit Grant Notice and Award Agreement (Filed With SEC on July 31, 2020)
- Non-Employee Director Compensation Program (Filed With SEC on May 11, 2020)
- Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934 (Filed With SEC on February 27, 2020)
- Third Amendment to Office Lease, dated December 20, 2019, by and between the Company and HCP Life Science REIT, Inc (Filed With SEC on February 27, 2020)
- Commercial Packaging Agreement, dated November 11, 2019, by and between AndersonBrecon Inc. and Aimmune Therapeutics, Inc (Filed With SEC on February 27, 2020)
- Amended and Restated Registration Rights Agreement, dated February 4, 2020, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 5, 2020)
- Amended and Restated Standstill Agreement, dated February 4, 2020, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 5, 2020)
- Amended and Restated Strategic Collaboration Agreement, dated February 4, 2020, by and between the Company and Socit des Produits Nestl S.A (Filed With SEC on February 5, 2020)
- Securities Purchase Agreement, dated February 4, 2020, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 5, 2020)
- License Agreement, dated February 4, 2020, by and among, Aimmune Therapeutics, Inc. and Xencor, Inc (Filed With SEC on February 5, 2020)
- Letter Agreement, dated December 19, 2019, between the Company and Stephen G. Dilly, M.B.B.S., Ph.D (Filed With SEC on December 20, 2019)
- Letter Agreement, dated June 13, 2019, by and between the Company and Stephen G. Dilly, M.B.B.S., Ph.D (Filed With SEC on August 8, 2019)
- Office Lease dated February 23, 2015, by and between, the Company, Diamond Marina LLC and Diamond Marina II LLC in June 2019 (Filed With SEC on August 8, 2019)
- Commercial Supply Agreement, dated May 10, 2019, by and between CoreRx, Inc. and Aimmune Therapeutics, Inc (Filed With SEC on August 8, 2019)
- Amended and Restated Registration Rights Agreement, dated November 11, 2018, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 28, 2019)
- Amended and Restated Standstill Agreement, dated November 11, 2018, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 28, 2019)
- Securities Purchase Agreement, dated November 11, 2018, by and between the Company and Nestle Health Science US Holdings, Inc (Filed With SEC on February 28, 2019)
- Amended and Restated Strategic Collaboration Agreement, dated November 11,2018, by and between the Company and Nestec Ltd (Filed With SEC on February 28, 2019)
- Executive Employment Agreement, dated June 4, 2018, by and between the Company and Jayson Dallas, M.D (Filed With SEC on August 8, 2018)
- Underwriting Agreement, dated as of February 21, 2018, among Aimmune Therapeutics, Inc. and Merrill, Lynch, Pierce, Fenner & Smith Incorporated, as representative of the... (Filed With SEC on February 26, 2018)
- Amended and Restated Supply Agreement, dated as of January 10, 2017, by and between the Company and Golden Peanut Company, L.L.C (Filed With SEC on February 20, 2018)
- Transition and Separation Agreement, dated November 5, 2017, by and between the Company and Stephen G. Dilly, M.B.B.S., Ph.D (Filed With SEC on November 6, 2017)
- Second Amendment to Office Lease, dated June 27, 2017, by and between, the Company, Diamond Marina LLC and Diamond Marina II LLC (Filed With SEC on August 8, 2017)
- Executive Employment Agreement, dated April 28, 2017, by and between the Company and Eric Bjerkholt (Filed With SEC on May 8, 2017)
- REGISTRATION RIGHTS AGREEMENT (Filed With SEC on March 15, 2017)
- Nestle Health Science US Holdings, Inc. 900 Long Ridge Road, Building 2 Stamford, CT 06902 (Filed With SEC on March 15, 2017)
- STRATEGIC COLLABORATION AGREEMENT between NESTEC LTD. and AIMMUNE THERAPEUTICS, INC. (Filed With SEC on March 15, 2017)
- AIMMUNE THERAPEUTICS, INC. SECURITIES PURCHASE AGREEMENT (Filed With SEC on March 15, 2017)
- TRANSITION AND SEPARATION AGREEMENT (Filed With SEC on February 3, 2017)
- AMENDMENT TO LEASE BY AND BETWEEN MYERLAKE, LLC. AND AIMMUNE THERAPEUTICS, INC. DATED JUNE 8, 2015 (Filed With SEC on August 10, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on August 10, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 16, 2016)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on May 16, 2016)
- Aimmune Therapeutics UK Ltd. UK Employment Agreement For Sue Barrowcliffe Employment Agreement (Filed With SEC on March 3, 2016)
- Jeff Knapp (Filed With SEC on March 3, 2016)
- Aimmune Therapeutics, Inc. Company Bonus Plan (Filed With SEC on February 25, 2016)
- TRANSITION AND SEPARATION AGREEMENT (Filed With SEC on November 4, 2015)
- FIRST AMENDMENT TO LEASE (Filed With SEC on August 31, 2015)
- Aimmune Therapeutics, Inc. Shares of Common Stock UNDERWRITING AGREEMENT (Filed With SEC on July 27, 2015)
- AIMMUNE THERAPEUTICS, INC. 2015 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE (Filed With SEC on July 27, 2015)
- AIMMUNE THERAPEUTICS, INC. 2015 EQUITY INCENTIVE AWARD PLAN STOCK OPTION GRANT NOTICE (Filed With SEC on July 27, 2015)
- AIMMUNE THERAPEUTICS, INC. 2015 EQUITY INCENTIVE AWARD PLAN RESTRICTED STOCK UNIT AWARD GRANT NOTICE (Filed With SEC on July 27, 2015)
- AIMMUNE THERAPEUTICS, INC. INDEMNIFICATION AGREEMENT (Filed With SEC on July 27, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 27, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 27, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 27, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 27, 2015)
- EXECUTIVE EMPLOYMENT AGREEMENT (Filed With SEC on July 27, 2015)
- AMENDED AND RESTATED SETTLEMENT AGREEMENT AND MUTUAL RELEASE OF CLAIMS (Filed With SEC on July 27, 2015)
- AIMMUNE THERAPEUTICS, INC. 2015 EMPLOYEE STOCK PURCHASE PLAN ARTICLE I. PURPOSE,SCOPE AND ADMINISTRATION OF THE PLAN (Filed With SEC on July 27, 2015)
- AIMMUNE THERAPEUTICS, INC. NON-EMPLOYEE DIRECTOR COMPENSATION PROGRAM (Filed With SEC on July 27, 2015)
- AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT (Filed With SEC on July 6, 2015)
- [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH... (Filed With SEC on July 6, 2015)
- OFFICE LEASE by andbetween Diamond Marina LLC, a California limited liability company, and Diamond Marina II LLC, a California limited liability company as Landlord and... (Filed With SEC on July 6, 2015)
- [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH... (Filed With SEC on July 6, 2015)
- ALLERGEN RESEARCH CORPORATION AMENDED AND RESTATED 2013 STOCK PLAN TABLE OF CONTENTS (Filed With SEC on July 6, 2015)
- AMENDMENT TO THE ALLERGEN RESEARCH CORPORATION 2013 STOCK PLAN EffectiveJanuary 20, 2015 (Filed With SEC on July 6, 2015)
- ALLERGEN RESEARCH CORPORATION NOTICE OF GRANT OF STOCK OPTION (IMMEDIATELY EXERCISABLE) (Filed With SEC on July 6, 2015)
- ALLERGEN RESEARCH CORPORATION NOTICE OF GRANT OF RESTRICTED STOCK (Filed With SEC on July 6, 2015)
- [***] CERTAIN INFORMATION IN THIS DOCUMENT HAS BEEN OMITTED AND FILED SEPARATELY WITH THE SECURITIES AND EXCHANGE COMMISSION. CONFIDENTIAL TREATMENT HAS BEEN REQUESTED WITH... (Filed With SEC on July 6, 2015)
